Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Targeted Mechanism of Action Presentations in Prescription Drug Promotion

---
identifier: "/us/fr/2022-27140"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Targeted Mechanism of Action Presentations in Prescription Drug Promotion"
title_number: 0
title_name: "Federal Register"
section_number: "2022-27140"
section_name: "Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Targeted Mechanism of Action Presentations in Prescription Drug Promotion"
positive_law: false
currency: "2022-12-14"
last_updated: "2022-12-14"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2022-27140"
document_type: "notice"
publication_date: "2022-12-14"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "87 FR 76492"
fr_volume: 87
docket_ids:
  - "Docket No. FDA-2021-N-1050"
fr_action: "Notice."
---


#  Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Targeted Mechanism of Action Presentations in Prescription Drug Promotion

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA or Agency) is announcing that a collection of information entitled “Targeted Mechanism of Action Presentations in Prescription Drug Promotion” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA).

**FOR FURTHER INFORMATION CONTACT:**

JonnaLynn Capezzuto, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, * 301-796-3794,**P**[email protected].*

**SUPPLEMENTARY INFORMATION:**

On October 14, 2022, the Agency submitted a proposed collection of information entitled “Targeted Mechanism of Action Presentations in Prescription Drug Promotion” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0908. The approval expires on November 30, 2025. A copy of the supporting statement for this information collection is available on the internet at *https://www.reginfo.gov/public/do/PRAMain.*

Dated: December 9, 2022.

Lauren K. Roth,

Associate Commissioner for Policy.